Daniel Van Meter is a pharmacist who is specialized in Oncology in New York, New York. Patients can reach him at 1275 York Ave, New York or contact him on 212-639-7155. Active license number of Daniel Van Meter is 033.0003817 for Oncology in Vermont. Daniel Van Meter is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Daniel Van Meter speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Daniel Van Meter
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Male
Location:
1275 York Ave, New York, New York, 10065-6007
Phone:
212-639-7155
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Daniel Van Meter are as mentioned below.
NPI Number:
1487902722
NPI Enumeration Date:
16 Aug, 2012
NPI Last Update On:
16 Aug, 2012
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Daniel Van Meter are as mentioned below.
Specialization
License Number
State
Status
Oncology
033.0003817
Vermont
Primary
Oncology
053108
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
475 Main St, Apt. 12 Q New York, New York
Zip:
10044-0085
Phone Number:
--
Fax Number:
--
Patients can reach Daniel Van Meter at 1275 York Ave, New York, New York or can call on phone at 212-639-7155.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.